Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
Department of Orthopedics and Trauma Surgery, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Wien Klin Wochenschr. 2024 Oct;136(19-20):547-555. doi: 10.1007/s00508-023-02267-4. Epub 2023 Aug 31.
A variety of treatment options for unicameral bone cysts (UBC) exist. The controversy of open management of UBC is discussed. The aim of this study was to analyze a single institution's experience in the open surgical treatment of UBC.
By retrospective analysis of the Vienna Bone and Soft Tissue Tumor Registry, 119 patients with open surgery and histologically verified UBC with a mean follow up of 4.8 years (range 1-30 years) were included. Lesion treatment failure was defined as surgically addressed UBC undergoing revision surgery due to persistence or recurrence.
Local revision-free survival for lesion treatment failure was 93% after 1 year, 80% after 2 years, 60% after 5 years and 57% after 10 years. Of the patients 34 (29%) had at least 1 revision surgery due to lesion treatment failure. We found that patients with lesion treatment failure were younger (p = 0.03), had UBC with less minimal distance to the growth plate (p = 0.02) and more septation chambers in radiologic imaging (p = 0.02). Patients with open revision surgery were less likely to require a second revision due to lesion treatment failure than patients with percutaneous revision surgery (p = 0.03).
Open surgery for UBC can only be recommended as reserve treatment in younger children with actively growing lesions. Open UBC surgery carries a relatively high risk of almost 30% of lesion treatment failure and therefore the indications should be limited to extensive osteolysis with high risk of pathological fractures, lesions with displaced pathological fractures, and lesions with an ambiguous radiological presentation that require tissue collection.
单房性骨囊肿(UBC)有多种治疗选择。目前正在讨论 UBC 开放性治疗的争议。本研究旨在分析单机构开放性手术治疗 UBC 的经验。
通过对维也纳骨与软组织肿瘤登记处的回顾性分析,纳入 119 例接受开放性手术和组织学证实的 UBC 患者,平均随访 4.8 年(1-30 年)。将病变治疗失败定义为接受手术治疗的 UBC 因持续存在或复发而再次接受手术。
1 年时病变治疗失败的局部无复发生存率为 93%,2 年时为 80%,5 年时为 60%,10 年时为 57%。34 例(29%)患者至少因病变治疗失败而接受了 1 次以上的手术。我们发现,病变治疗失败的患者更年轻(p=0.03),病变与生长板的最小距离更小(p=0.02),影像学表现中的分隔腔更多(p=0.02)。与经皮翻修手术相比,接受开放性翻修手术的患者因病变治疗失败而再次需要翻修的可能性更小(p=0.03)。
对于生长活跃的年轻患儿,开放性手术仅可作为 UBC 的保留治疗。开放性 UBC 手术的病变治疗失败风险相对较高,约为 30%,因此适应证应限于广泛的溶骨性病变、有发生病理性骨折高风险的病变、有移位的病理性骨折的病变以及影像学表现不明确需要采集组织的病变。